Intraepithelial Neoplasia
10
2
2
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
10%
1 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (10)
NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer
NWRD09 for HPV-16 Positive and HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer Patients.
HRME in the Screening of Cervical Cancer Precursor Lesions in Brazil (UH3 - Brazil)
Difference of Gastric Microbiota in the Process of Correa's Model.
Cervical And Self-Sample In Screening Study
Endoscopic Multispectral Imaging for the Early Detection of Barrett's Neoplasia
Clinical Evaluation of Bioadhesive Gels for Oral Cancer Chemoprevention
Triage Strategies in Cervical Cancer Prevention
Genotypification and Predisposing Factors in Human Papilloma Virus Infection
Chromoscopic Guided Endomicroscpy to Diagnose Colitis Associated Dysplasia